aid: ausperbio
name: AusperBio
description: 'AusperBio — AusperBio Therapeutics, Inc. in the United States and Ausper
  Biopharma Co., Ltd. (杭州浩博医药有限公司) in Hangzhou, China — is a clinical-stage
  biopharmaceutical company founded in 2019 that develops oligonucleotide and targeted
  delivery technologies, with an initial focus on achieving a functional cure for chronic
  hepatitis B infection. Its proprietary Med-Oligo antisense oligonucleotide (ASO) platform
  pairs novel ASO design and optimization with targeted delivery conjugation chemistry,
  and its Au-HALO hepatocyte-targeting delivery technology extends the same modular
  approach to siRNA. The lead candidate AHB-137 is an unconjugated ASO that completed
  enrollment in two Phase II trials and received China CDE clearance to enter Phase III;
  a second clinical candidate, AHB-171, is a hepatocyte-targeted siRNA. The company has
  raised more than $200M across Series B, B+ and B2 rounds from investors including
  Qiming Venture Partners, HanKang Capital, CDH Investments, Sherpa Capital, YuanBio
  Venture Capital and Genesis Capital. AusperBio sells therapeutics, not software: it
  publishes no developer program, no public API, no SDK and no machine-readable API
  contract. Its only machine-readable surface is the private Spring Boot CMS backend that
  renders ausperbio.com, whose springdoc API description is correctly locked behind
  authentication.'
image: https://www.ausperbio.com/favicon.ico
url: https://raw.githubusercontent.com/api-evangelist/ausperbio/refs/heads/main/apis.yml
x-type: company
x-source: harvest:secondary-market
x-tier: profile
x-tier-reason: no-api-surface
specificationVersion: '0.23'
created: '2026-08-06'
modified: '2026-08-06'
tags:
- Company
- Biotechnology
- Pharmaceuticals
- Biopharmaceutical
- Life Sciences
- Therapeutics
- Oligonucleotide
- Antisense Oligonucleotide
- siRNA
- Clinical Trials
- Hepatitis B
- Drug Development
- Health
- China
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: DomainSecurity
  url: security/ausperbio-domain-security.yml
- type: Website
  url: https://www.ausperbio.com/
- type: About
  url: https://www.ausperbio.com/company.html
- type: Team
  url: https://www.ausperbio.com/leadership.html
- type: Product
  url: https://www.ausperbio.com/platform.html
  description: Med-Oligo ASO platform and Au-HALO targeted delivery technology.
- type: Research
  url: https://www.ausperbio.com/pipeline.html
  description: Clinical pipeline — AHB-137 (ASO) and AHB-171 (siRNA) for chronic hepatitis B.
- type: Blog
  url: https://www.ausperbio.com/news.html
- type: News
  url: https://www.ausperbio.com/news.html
- type: Support
  url: https://www.ausperbio.com/contact-us.html
- type: Contact
  url: https://www.ausperbio.com/contact-us.html
- type: Careers
  url: https://www.ausperbio.com/careers.html
- type: TermsOfService
  url: https://www.ausperbio.com/term.html
- type: PrivacyPolicy
  url: https://www.ausperbio.com/privacy.html
- type: LinkedIn
  url: https://www.linkedin.com/company/ausperbio
- type: LLMsTxt
  url: llms/ausperbio-llms.txt

x-enrichment:
  date: '2026-08-06'
  status: minimal
  artifacts_added: 2
  pass: local-v1

x-coverage:
  state: none
  reason: not-a-software-company
  detail: >-
    AusperBio develops antisense-oligonucleotide and siRNA drugs for chronic hepatitis B,
    so there is no software product to expose; ausperbio.com is a Vue single-page app that
    returns an identical 2,601-byte shell (md5 519d85ce…) for every path including invented
    ones, and the only machine-readable API description on the estate is the springdoc
    description of the private Spring Boot CMS at cms.ausperbio.com/jzy-admin/, which is
    correctly 401-gated and is site infrastructure rather than a product surface.
  evidence:
  - url: https://www.ausperbio.com/openapi.json
    status: 200
    note: Soft 404 — byte-identical to the SPA shell returned for a nonexistent control path.
  - url: https://www.ausperbio.com/definitely-not-a-real-path-zzz999
    status: 200
    note: Control path proving every 200 on this host is the SPA catch-all.
  - url: https://www.ausperbio.com/llms.txt
    status: 200
    note: Soft 404 — SPA shell, not an llms.txt.
  - url: https://www.ausperbio.com/.well-known/agent-card.json
    status: 200
    note: Soft 404 — SPA shell, not an agent card. No A2A card published.
  - url: https://cms.ausperbio.com/jzy-admin/v3/api-docs
    status: 200
    note: 'Returns {"code":401,"msg":""} — springdoc API description exists but is
      authentication-gated.'
  - url: https://cms.ausperbio.com/jzy-admin/doc.html
    status: 401
  - url: https://api.ausperbio.com/
    status: 0
    note: No such host in DNS. Same for developer. and docs. subdomains.
  checked: '2026-08-06'